Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
208.47
-0.76 (-0.37%)
Jul 30, 2026, 2:55 PM EDT - Market open

Biogen Stock Forecast

Stock Price Forecast

According to 36 analysts polled by S&P Global, Biogen stock has a consensus rating of "Buy" and an average price target of $233.87. The average 1-year stock price forecast is 12.19% higher than the current stock price, while the lowest is $157 (-24.69%) and the highest is $300 (+43.91%).

Price Target: $233.87 (+12.19%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$157$233.87$236$300
Change-24.69%+12.19%+13.21%+43.91%

Analyst Ratings

The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy141417181820
Buy112233
Hold202016151412
Sell000000
Strong Sell111111
Total363636363636

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
$255
BuyMaintains$255+22.32%Jul 30, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$237$251
BuyReiterates$237$251+20.40%Jul 30, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aJul 30, 2026
UBS
UBS
Buy
Maintains
$225$240
BuyMaintains$225$240+15.13%Jul 30, 2026
BMO Capital
BMO Capital
Hold
Reiterates
$196$208
HoldReiterates$196$208-0.22%Jul 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.06B
from 9.89B
Increased by 1.75%
Revenue Next Year
10.32B
from 10.06B
Increased by 2.53%
EPS This Year
11.98
from 15.28
Decreased by -21.59%
EPS Next Year
16.42
from 11.98
Increased by 37.02%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
10.98B10.17B9.84B9.68B9.89B10.06B
Revenue Growth
-18.32%-7.36%-3.32%-1.62%2.22%1.75%
Gross Profit
8.87B7.90B7.30B7.55B7.81B7.81B
Gross Margin
80.79%77.61%74.24%78.00%78.95%77.58%
Operating Income
3.44B3.02B1.90B2.61B2.85B2.55B
Net Income
1.56B3.05B1.16B1.63B1.29B1.29B
EPS
----15.2811.98
EPS Growth
-----7.23%-21.59%
Forward PE
13.9417.7017.549.7113.6617.40
Free Cash Flow
2.21B1.39B981.44M3.45B1.95B2.53B
No. Analysts
-----28
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.7B
Avg10.1B
Low9.6B

Revenue Growth

Revenue Growth202620272028
High
8.3%
Avg
1.8%
Low
-3.1%

EPS Forecast

EPS202620272028
High15.33
Avg11.98
Low-10.65

EPS Growth

EPS Growth202620272028
High
0.3%
Avg
-21.6%
Low-